Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival Akiko Tanaka, MD, PhD, David Onsager, MD, Tae Song, MD, Daniel Cozadd, MD, Gene Kim, MD, Nitasha Sarswat, MD, Sirtaz Adatya, MD, Gabriel Sayer, MD, Nir Uriel, MD, Valluvan Jeevanandam, MD, Takeyoshi Ota, MD, PhD The Annals of Thoracic Surgery Volume 103, Issue 3, Pages 725-733 (March 2017) DOI: 10.1016/j.athoracsur.2016.06.078 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Grouping chart. (AVr = aortic valve repair; AVR = aortic valve replacement; MR = mitral regurgitation.) The Annals of Thoracic Surgery 2017 103, 725-733DOI: (10.1016/j.athoracsur.2016.06.078) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 (A) Recurrent mitral valve regurgitation-free rate (Kaplan-Meier curve) of discharged patients. (B) Overall survival rate, freedom from all-cause death (Kaplan-Meier curve). (C) Heart failure readmission-free rate (Kaplan-Meier curve) of discharged patients. Blue lines indicate surgical correction group; red lines indicate spontaneous correction group. (LVAD = left ventricular assist device.) The Annals of Thoracic Surgery 2017 103, 725-733DOI: (10.1016/j.athoracsur.2016.06.078) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions